Science Explorer Back to mapMap
Discussion
Researcher · Leo Pharma (Denmark) · Denmark

Leif Tybring

Leif Tybring publishes mostly in Pharmacology, Organic Chemistry and Molecular Biology, on topics such as Antibiotics Pharmacokinetics and Efficacy, Antibiotic Resistance in Bacteria and Phenothiazines and Benzothiazines Synthesis and Activities.

OpenAlex
World rank
#1,581,056
of 7,710,434 ranked researchers
Rank in Denmark
#11,975
of 43,819
Works
27
Citations
1.2k
Citations per work
43.1
h-index
12
i10-index 14Top 48% in Pharmacology (Medicine)
Leif Tybring

What does Leif Tybring research?

Leif Tybring's work is mostly in Medicine (30%), Biochemistry, Genetics and Molecular Biology (23%), Chemistry (21%).

Health Sciences: 8 works · 30.2% of their workMedicine: 8 works · 30.2% of their workPharmacology: 7 works · 24.7% of their workInfectious Diseases: 1 works · 5.5% of their workEverything else: 7 works · 25.9% of their workLife Sciences: 6 works · 23.3% of their workBiochemistry, Genetics and Molecular Biology: 6 works · 23.3% of their workMolecular Biology: 4 works · 13.7% of their workMolecular Medicine: 3 works · 9.6% of their workPhysical Sciences: 6 works · 20.6% of their workChemistry: 6 works · 20.6% of their workOrganic Chemistry: 4 works · 15.1% of their workAnalytical Chemistry: 1 works · 5.5% of their workTHEIR WORKLeif Tybring27works
Life Sciences23%Physical Sciences21%Health Sciences30%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine830.2%
  2. Everything else725.9%
    1. Biochemistry, Genetics and Molecular Biology623.3%
    1. Chemistry620.6%
  1. 1Pharmacology25% of their works
  2. 2Organic Chemistry15% of their works
  3. 3Molecular Biology14% of their works
  4. 4Molecular Medicine10% of their works
  5. 5Infectious Diseases6% of their works
  6. 6Analytical Chemistry6% of their works

Research topics

Which keywords describe Leif Tybring's research?

The keywords of their largest research topics: Antimicrobial Resistance, Antibiotic Pharmacokinetics, Critically Ill Patients, Antibiotic Resistance, Multidrug-Resistant Bacteria, Biological Activities, Phenothiazines and Green Analytical Chemistry.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 17 words, with their numbers
  1. Antimicrobial Resistance152 topics
  2. Antibiotic Pharmacokinetics121 topic
  3. Critically Ill Patients121 topic
  4. Antibiotic Resistance71 topic
  5. Multidrug-Resistant Bacteria71 topic
  6. Biological Activities51 topic
  7. Phenothiazines51 topic
  8. Green Analytical Chemistry41 topic
  9. HLA-B*570141 topic
  10. Pharmaceutical Analysis41 topic
  11. Stevens-Johnson Syndrome41 topic
  12. Heterocyclic Compounds31 topic
  13. MRSA31 topic
  14. Medicinal Chemistry31 topic
  15. Off-Label Drug Use31 topic
  16. Pediatric Pharmacokinetics31 topic
  17. Staphylococcus aureus31 topic

Where does Leif Tybring work?

Leif Tybring's main affiliation in the publication record is Leo Pharma (Denmark), Denmark.

How many publications and citations does Leif Tybring have?

OpenAlex counts 27 works and 1,164 citations for Leif Tybring, an h-index of 12, ranking #1,581,056 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Leif Tybring. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.